Background

Tilray

Medical Cannabis

Nanaimo, British Colombia, Canada
NASDAQ: TLRY
www.tilray.com

Company Overview

Tilray is a Canadian pharmaceutical and cannabis company headquartered in Nanaimo, British Columbia. Tilray is one of the largest and most sophisticated producers of premium medical cannabis in the world.

Tilray's Latest Available Job Postings

Your centralized place on the web for everything Tilray, careers, and company information. Careers Cannabis.

Quality Assurance Assistant-Leamington
Tilray

Familiarity with the Cannabis Act and Cannabis Regulations is an ...

View Job Posting
Manufacturing Supervisor-Leamington
Tilray

High Park Company was established to develop, sell, and distribut...

View Job Posting
Manufacturing Execution Support Technician-Leamington
Tilray

High Park Company was established to develop, sell, and distribut...

View Job Posting
Field Sales Representative - Toronto
Tilray

Knowledge of cannabis industry, cannabis strains, terpenes, and c...

View Job Posting
Brand Manager - Grail
Tilray

High Park, a wholly-owned subsidiary of Tilray, was established t...

View Job Posting
Global GMP Auditor
Tilray

Tilray is a federally licensed producer of medical cannabis. Know...

View Job Posting
Field Sales Specialist - Edmonton
Tilray

Tilray is a federally licensed producer of medical cannabis. High...

View Job Posting
Head Grower - Cannabis
Tilray

High Park Company is seeking a Head Grower - Cannabis (NOC 0822:....

View Job Posting
Documentation and Labeling Technician
Tilray

High Park Company was established to develop, sell, and distribut...

View Job Posting
Regional Business Manager - Maritime
Tilray

High Park Company was established to develop, sell, and distribut...

View Job Posting

Recent News Articles

These 13 stocks are spring-loaded for a surge as it gets too expensive to short them

Borrowing costs for some of the market's most-shorted stocks are skyrocketing and creating a situation where short sellers are at risk of getting squeezed, according to a new study from financial technology and analytics firm S3 Partners. When short sellers c…